BANK OF AMERICA CORP /DE/
BankPosition in IOVA — Iovance Biotherapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in IOVA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$29,800,316
-$9,178,111 QoQ
Shares Held
8,490,119
-40.5% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Derivatives in IOVA
reported options exposure · as of Sep 30, 2022CallValue
$466,546
CallShares
48,700
PutValue
$466,546
PutShares
48,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. IOVA ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in IOVA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,800,316 | 8,490,119 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $38,978,427 | 14,277,813 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,625,928 | 6,279,230 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,930,855 | 4,029,568 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,047,223 | 3,017,185 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,486,491 | 741,418 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,013,365 | 2,450,838 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,381,140 | 2,167,225 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,708,742 | 1,532,304 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,616,890 | 936,887 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,596,809 | 1,230,068 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,112,158 | 1,294,341 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,754,227 | 1,432,771 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,543,596 | 1,180,532 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $466,546 | 48,700 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $5,433,927 | 567,216 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $466,546 | 48,700 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $3,473,689 | 314,646 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,036,376 | 1,023,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,097,971 | 790,884 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $13,712,683 | 556,070 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,984,549 | 460,590 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $82,517,227 | 2,606,356 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $148,594,512 | 3,202,468 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $106,385,750 | 3,231,645 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $89,503,137 | 3,260,588 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $96,227,726 | 3,214,019 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||